The last time I spoke about Solid Biosciences Inc. (SLDB), it was with respect to a Seeking Alpha article entitled "Solid Biosciences: Differentiating Factors Of SGT-212 To Set Itself Apart". With ...

Cross-sectional data from 45 functionally intact older women at heightened risk for Alzheimer's disease suggested that short sleep durations amplified the association between APOE4 status and tau, but ...

Less than two weeks after rejecting Sanofi’s investigational multiple sclerosis drug, the FDA has publicly shared the complete response letter, citing both efficacy and safety concerns—including a ...

JavaScript is disabled in your web browser or browser is too old to support JavaScript. Today almost all web pages contain JavaScript, a scripting programming language that runs on visitor's web ...

Investing in resilience before disaster strikes is not only essential; it's a rational choice for managing risks, preventing massive losses and securing long-term benefits for entire communities. This ...

Intellia Therapeutics is downgraded to Sell due to safety concerns and weak commercial prospects in ATTR and HAE. NTLA's ATTR program faces a clinical hold after a Hy’s-law-threshold liver event, with ...

Young people across South and Southeast Asia have grown up online, frustrated and impatient with their leaders. As jobs dry up and inequality widens, their protests are shaking even the most ...

Timor-Leste has tried for years to join Southeast Asia's most significant regional body, hoping it would pave the way for more investment in the country. Timor-Leste is set to become the newest member ...

The retailer, which recently merged with Sigma Healthcare, is using Alation software to implement a data governance framework that it designed in conjunction with a partner. Data strategy and ...

Artificial Intelligence (AI) is disrupting information consumption worldwide, including in one of the world’s youngest democracies, even though it barely speaks the local language – yet. Timor-Leste ...